皮质护士对抗癌症:在早期瘤控制中整合细胞竞争和挤出
Grecia Riofrio-Chung1, César Rivera2
1Oral and Maxillofacial Histopathology Laboratory, Department of Stomatology, Faculty of Dentistry, Universidad de Talca, Avenida Lircay S/N, Campus Norte, Oficina N°4, Talca, Chile.
Discover oncology
|October 9, 2025
概括
皮质抗癌防御 (EDAC) 机制,包括细胞竞争和挤出,清除癌前细胞以防止瘤形成. 了解EDAC为癌症预防和治疗提供了新的途径.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物物理学的生物物理.
背景情况:
- 表皮组织拥有内在的机制来消除癌前细胞,防止癌症的发展.
- 细胞竞争和挤出是关键的过程,这些过程被称为表皮细胞抗癌防御 (EDAC).
研究的目的:
- 审查最近在上皮细胞抗癌防御 (EDAC) 机制方面的进展.
- 探索影响EDAC的分子和生物力学因素.
- 研究EDAC在特定癌症模型中的作用及其治疗潜力.
主要方法:
- 文献综述综合了最近关于EDAC的研究.
- 分析EDAC所涉及的分子通路,蛋白相互作用和生物机械线索.
- 检查癌症模型,包括胰腺癌,结肠直肠癌和乳腺癌.
主要成果:
- EDAC涉及正常细胞超越或驱逐转化细胞.
- 关键蛋白质和生物力学信号对于有效的EDAC至关重要.
- 特定的细胞比例对于EDAC的有效性至关重要.
- 在各种癌症类型中,EDAC在预防瘤发生方面发挥着作用.
结论:
- 表皮细胞对抗癌症防御 (EDAC) 是对瘤发生的关键先天性防御机制.
- 在开发新型癌症预防和治疗策略方面,EDAC是一个有前途的前沿.
- 对EDAC分子和生物力学基础的进一步研究可以释放其临床潜力.
相关概念视频
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Cancer Cell Migration through Invadopodia
3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.6K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K


